iShares MSCI Israel ETF (NYSEARCA:EIS) Sets New 12-Month High – Still a Buy?

iShares MSCI Israel ETF (NYSEARCA:EISGet Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $137.06 and last traded at $136.93, with a volume of 27768 shares. The stock had previously closed at $133.83.

iShares MSCI Israel ETF Price Performance

The firm has a market cap of $1.03 billion, a price-to-earnings ratio of 13.79 and a beta of 1.03. The firm has a fifty day simple moving average of $125.91 and a two-hundred day simple moving average of $118.35.

Institutional Investors Weigh In On iShares MSCI Israel ETF

Institutional investors and hedge funds have recently modified their holdings of the company. O Shaughnessy Asset Management LLC acquired a new stake in shares of iShares MSCI Israel ETF during the fourth quarter worth about $26,000. Ameritas Advisory Services LLC acquired a new stake in shares of iShares MSCI Israel ETF during the third quarter worth about $25,000. Triumph Capital Management acquired a new stake in shares of iShares MSCI Israel ETF during the third quarter worth about $37,000. AlphaCore Capital LLC acquired a new stake in shares of iShares MSCI Israel ETF during the third quarter worth about $40,000. Finally, Princeton Global Asset Management LLC lifted its holdings in shares of iShares MSCI Israel ETF by 41.3% during the first quarter. Princeton Global Asset Management LLC now owns 428 shares of the company’s stock worth $50,000 after purchasing an additional 125 shares during the period.

About iShares MSCI Israel ETF

(Get Free Report)

The iShares MSCI Israel ETF (EIS) is an exchange-traded fund that is based on the MSCI Israel Capped index, a market-cap-weighted index of Israeli firms. EIS was launched on Mar 26, 2008 and is managed by BlackRock.

Further Reading

Receive News & Ratings for iShares MSCI Israel ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares MSCI Israel ETF and related companies with MarketBeat.com's FREE daily email newsletter.